about
[Liver transplantation with cavoportal or renoportal anastomosis: a solution in cases of diffuse portal thrombosis].[Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience].Decision for retransplantation of the liver: an experience- and cost-based analysis.In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection.Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang.Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience.Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases.Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experienceCaval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastasesInterest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trialHepatic resection after down-staging of unresectable hepatic colorectal metastases.Short- and long-term results of extended left hepatectomy for colorectal metastasesCentral Hepatectomy versus Extended Hepatectomy for Malignant Tumors: A Propensity Score Analysis of Postoperative Complications.Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience.Therapeutic strategies in symptomatic portal biliopathy.A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation.Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysisManagement of excluded segmental bile duct leakage following liver resectionPlasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases: A Propensity Score-based Analysis.Risk factors associated with outcome in liver retransplantation: multicentric study.Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers.Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.Donor age influences 10-year liver graft histology independently of hepatitis C virus infection.R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation.Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases.Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients.Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study.Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era.Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma.Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?Liver resection for colorectal metastases: the third hepatectomy.
P50
Q33183829-1F2F3C69-DF49-473A-BAF1-92E2186189ADQ33185173-28E19046-9A7A-4735-BA64-5C735A0B797FQ33185263-122B33A3-0DF2-426F-BF67-8BF3E57761D2Q33210868-441237F7-F451-43C3-8524-78555839B4EBQ33217692-D37566B5-ACEA-4F18-A470-982B7E8D1CC8Q33247711-B5E0BA4F-7A56-43DD-A3B6-2EB84AFD8F8FQ33735465-E868BDF3-038F-400E-BC2A-3F4D846E803CQ33960714-5666183C-3231-4A39-8802-B226B0DF2D1AQ34003453-F8FA0FBF-91B2-42D3-BDEE-862751E603F2Q34551117-FD85F47E-8F0E-49B0-84F9-E4BD9C5DBB9AQ34601615-5A84BE92-AAA9-4464-92AE-9D16C121B418Q34996252-1C320EE9-61BE-49B3-8BA1-5668DA8CF01BQ35123019-80C3950F-A8D8-4669-8AC6-F583D069FD0FQ35185190-04606817-ADFB-44A6-A9F6-D08249499080Q36043789-3E9F565B-092A-46C9-B60B-4807AD312ABFQ36253253-FD875104-DD7D-40D9-9513-F4E4498248E6Q36860473-6C6ABDCA-D7BA-4F00-8F89-217FB364A74CQ36903588-A1A57A51-5432-40F6-BEC2-3DF4980C50C4Q37231430-8E8BE368-2431-4E0C-82DB-53DA813A8ADDQ37589475-D3E6C475-8239-4BEC-ADB6-FCABD71BD1C2Q39902311-90CD8E93-90A8-4104-AED6-CF5B20007CE8Q40304044-EB536402-7F3E-44A8-850D-A8074DDCFD26Q41955039-14081AC6-D8FD-4711-BDA5-5BFC2321585AQ42635558-9CF1945D-6C52-46BA-923A-E8EC97374F35Q44136661-96D3E368-23DF-47A5-BF23-C20DEEF181DEQ44706610-DC68AFCA-27FD-4040-9ACE-63211113669FQ45166892-C174C96D-6D16-4139-8D50-00F09DAA69FCQ45398475-E0970725-312E-48C6-8919-0D8F4D9FA841Q45511696-2DCFE55D-B49D-4519-8EC0-1D9B88D12E35Q45595201-2599639D-EDD2-4F68-B2CA-A402A0FD3D43Q45674652-21A4F807-F301-437E-B1FD-3240549ED6E7Q46082144-0C6F2D3C-91D1-4803-BCE5-749A9EA5A981Q46538953-9C4E01F4-3447-486F-AA7C-1AA6D10223C2Q46603114-A08D8BFB-BF16-4D86-8B1F-7387187A7795Q46904681-683A088B-CE5D-4534-AB10-8F28615F3FE0Q46958955-8E485663-AD46-4271-A6DA-BD2FDB6136E8Q46986014-7649694B-6D93-41E2-BBB9-167888CC24CBQ47118575-6A49E175-6900-4F1B-A8C8-345064E46B20Q47275437-E7CAC01F-DB78-4089-A3D8-8E27624F22DCQ47371846-D7A71D33-3230-4280-9B7D-D3F3B71E9A60
P50
name
René Adam
@en
type
label
René Adam
@en
prefLabel
René Adam
@en